In pristane-induced lupus mouse model, TLR2−/− mice show lower ANA levels and reduced lupus pathogenesis, together with a reduced level of HMGB1, a well-known endogenous TLR ligand [73]. This evidence concerns the gene TLR2 and systemic lupus erythematosus.